Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Potent Anti-Inflammatory and Pro-Resolving Effects of Anabasum in a Human Model of Self-Resolving Acute Inflammation
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2017-12-14
DOI
10.1002/cpt.980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- WS01.5 A Phase 2 study of the safety, pharmacokinetics, and efficacy of anabasum (JBT-101) in cystic fibrosis (CF)
- (2017) J.F. Chmiel et al. Journal of Cystic Fibrosis
- Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics
- (2017) Justin T. English et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- Resolvin D3 multi-level proresolving actions are host protective during infection
- (2016) Paul C. Norris et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation
- (2015) R E Abdulnour et al. Mucosal Immunology
- Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity
- (2014) Mark A. Tepper et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Anti-TNF therapy: past, present and future
- (2014) C. Monaco et al. INTERNATIONAL IMMUNOLOGY
- Endotoxin detection in end-stage kidney disease
- (2014) Jonathan Wong et al. JOURNAL OF CLINICAL PATHOLOGY
- Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2
- (2014) Alastair J O'Brien et al. NATURE MEDICINE
- Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Potent Immunoresolvents
- (2013) Jesmond Dalli et al. CHEMISTRY & BIOLOGY
- Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis
- (2012) Estrella Garcia Gonzalez et al. ANNALS OF THE RHEUMATIC DISEASES
- Infection regulates pro-resolving mediators that lower antibiotic requirements
- (2012) Nan Chiang et al. NATURE
- Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4
- (2009) Robert B. Zurier et al. FASEB JOURNAL
- Efferocytosis impairs pulmonary macrophage and lung antibacterial function via PGE2/EP2 signaling
- (2009) Alexandra I. Medeiros et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis
- (2009) Matthew Spite et al. NATURE
- Cyclic AMP
- (2008) Carlos H. Serezani et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells
- (2008) Judith A. Stebulis et al. LIFE SCIENCES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search